- Home
- DLHC vs MNOV Comparison
DLHC vs MNOV Comparison
Compare DLHC & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- MNOV
- Stock Information
- Founded
- DLHC 1969
- MNOV 2000
- Country
- DLHC United States
- MNOV United States
- Employees
- DLHC N/A
- MNOV N/A
- Industry
- DLHC Business Services
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- DLHC Consumer Discretionary
- MNOV Health Care
- Exchange
- DLHC Nasdaq
- MNOV Nasdaq
- Market Cap
- DLHC 79.7M
- MNOV 65.7M
- IPO Year
- DLHC N/A
- MNOV 2005
- Fundamental
- Price
- DLHC $5.93
- MNOV $1.38
- Analyst Decision
- DLHC
- MNOV Strong Buy
- Analyst Count
- DLHC 0
- MNOV 2
- Target Price
- DLHC N/A
- MNOV $7.00
- AVG Volume (30 Days)
- DLHC 32.4K
- MNOV 63.0K
- Earning Date
- DLHC 08-06-2025
- MNOV 08-14-2025
- Dividend Yield
- DLHC N/A
- MNOV N/A
- EPS Growth
- DLHC 80.25
- MNOV N/A
- EPS
- DLHC 0.31
- MNOV N/A
- Revenue
- DLHC $359,723,000.00
- MNOV $134,599.00
- Revenue This Year
- DLHC N/A
- MNOV N/A
- Revenue Next Year
- DLHC N/A
- MNOV N/A
- P/E Ratio
- DLHC $18.18
- MNOV N/A
- Revenue Growth
- DLHC N/A
- MNOV N/A
- 52 Week Low
- DLHC $2.72
- MNOV $1.13
- 52 Week High
- DLHC $10.88
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- DLHC 66.14
- MNOV 58.77
- Support Level
- DLHC $5.50
- MNOV $1.32
- Resistance Level
- DLHC $5.60
- MNOV $1.43
- Average True Range (ATR)
- DLHC 0.13
- MNOV 0.04
- MACD
- DLHC 0.04
- MNOV 0.00
- Stochastic Oscillator
- DLHC 100.00
- MNOV 70.59
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.